Opportunity Information: Apply for PAR 11 023

  • The Agency for Health Care Research and Quality in the health sector is offering a public funding opportunity titled "Patient Safety and Medical Liability Reform Planning Projects (R21)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.226 Research on Healthcare Costs, Quality and Outcomes.
  • This funding opportunity was created on Mar 6, 2012 and posted on Nov 9, 2010.
  • Applicants must submit their applications by Mar 15, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) County governments Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education City or township governments Native American tribal governments (Federally recognized) State governments.
  • Other Eligible Applicants include the following Eligible Agencies of the Federal Government Indian/Native American Tribal Governments (Other than Federally Recognized).
Apply for PAR 11 023

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Patient Safety and Medical Liability Reform Planning Projects (R21) grant opportunity (Funding Opportunity Number PAR 11-023) was offered by the Agency for Health Care Research and Quality (AHRQ) to support short, early-stage planning work that could later grow into full demonstration projects. The central idea is that improvements in patient safety and reforms to medical liability should be developed together, not as separate efforts. Applicants are expected to plan projects that put patient safety first by reducing preventable patient injuries, strengthening communication between clinicians and patients, and creating fairer, faster pathways for compensating patients who experience medical harm. At the same time, the planned approach should aim to lower unnecessary legal friction in the system, including reducing frivolous lawsuits and helping address pressure on liability premiums, all while keeping an eye on reducing overall health care costs.

A key theme of the announcement is the connection between patient safety events and medical liability claims. Planning projects are intended to examine how adverse events arise, how they are disclosed and handled, and how those processes influence whether claims occur, how long they take, and how costly and contentious they become. In practical terms, the planning period should be used to design and prepare a cohesive model that aligns safety practices (such as error prevention, improved reporting, and learning systems) with liability-related practices (such as disclosure practices, early resolution options, or structured compensation approaches). The end goal is to optimize promising practices that can both improve outcomes for patients and reduce avoidable spending tied to preventable harm and litigation.

This opportunity used the R21 research grant mechanism and fell under a discretionary grant category with a health-focused activity classification. It was associated with CFDA 93.226 (Research on Healthcare Costs, Quality and Outcomes), and it did not require cost sharing or matching funds. The announcement was originally posted on November 9, 2010, later archived on April 15, 2012, and it listed multiple key dates, including an original closing date of January 7, 2014, a current closing date of March 15, 2012, and an archive date indicating the period when the announcement was no longer active for new submissions.

Eligibility was broad and included public and state-controlled institutions of higher education, private institutions of higher education, state governments, county governments, and city or township governments. It also included Native American tribal governments (federally recognized) and other Native American tribal organizations, along with other eligible agencies of the federal government as described in the opportunity materials. In other words, the program was structured to allow participation from a range of public-sector entities, academic institutions, and tribal governments that could credibly plan a safety-and-liability reform model and position it for later real-world demonstration.

For applicants or interested parties needing the full official announcement language and requirements, the funding notice pointed to an NIH-hosted grants page (http://grants.nih.gov/grants/guide/pa-files/PAR-11-023.html). The contact listed for access and linking issues was the NIH Office of Extramural Research (OER) webmaster (FBOWebmaster@OD.NIH.GOV), reflecting that the administrative posting and access support was handled through NIH’s grants infrastructure even though AHRQ was the sponsoring agency.

Frequently Asked Questions (FAQs)

What is the name of this grant opportunity?

The opportunity is titled Patient Safety and Medical Liability Reform Planning Projects (R21).

What is the Funding Opportunity Number?

The Funding Opportunity Number is PAR 11-023.

Which agency offered this opportunity?

The opportunity was offered by the Agency for Health Care Research and Quality (AHRQ).

What type of work was this grant intended to support?

It was designed to support short, early-stage planning work that could later develop into full demonstration projects.

What grant mechanism was used?

This opportunity used the R21 research grant mechanism.

What is the central idea behind the program?

The core premise is that patient safety improvements and medical liability reforms should be developed together as a single, integrated effort, rather than as separate initiatives.

What does it mean to “put patient safety first” in the planned projects?

Planning projects were expected to prioritize patient safety by focusing on topics such as reducing preventable patient injuries, strengthening communication between clinicians and patients, and improving how harm is prevented, identified, and addressed.

How does medical liability reform fit into the planned work?

The planned approach was expected to create fairer and faster pathways for compensating patients who experience medical harm, while also aiming to reduce unnecessary legal friction in the system.

What kinds of legal-system problems was the program trying to reduce?

The announcement highlighted goals such as reducing frivolous lawsuits and helping address pressure on liability premiums, while still keeping patient safety and fair resolution processes at the center.

How does the opportunity connect patient safety events and liability claims?

A key theme is that planning projects should examine how adverse events arise, how they are disclosed and handled, and how those processes affect whether claims occur, how long they take, and how costly or contentious they become.

What were applicants expected to do during the planning period?

The planning period was intended for designing and preparing a cohesive model that aligns safety practices (such as error prevention, reporting, and learning systems) with liability-related practices (such as disclosure practices, early resolution options, or structured compensation approaches).

What kinds of patient safety practices are mentioned as examples?

The opportunity references safety practices such as error prevention, improved reporting, and learning systems.

What kinds of medical liability practices are mentioned as examples?

The opportunity references liability-related practices such as disclosure practices, early resolution options, and structured compensation approaches.

What was the intended end goal of these planning projects?

The end goal was to optimize promising practices that could both improve outcomes for patients and reduce avoidable spending associated with preventable harm and litigation.

Was the opportunity connected to health care cost reduction?

Yes. The announcement emphasized reducing overall health care costs, including avoidable spending tied to preventable harm and litigation, while pursuing patient safety and fair compensation pathways.

What program classification details were provided (CFDA and activity type)?

It was associated with CFDA 93.226 (Research on Healthcare Costs, Quality and Outcomes) and was described as a discretionary grant with a health-focused activity classification.

Did the opportunity require cost sharing or matching funds?

No. The opportunity stated that it did not require cost sharing or matching funds.

When was the announcement originally posted?

The announcement was originally posted on November 9, 2010.

When was the announcement archived?

The announcement was archived on April 15, 2012, indicating it was no longer active for new submissions.

What closing dates were listed?

The announcement listed multiple key dates, including an original closing date of January 7, 2014 and a current closing date of March 15, 2012, along with the archive date that signals when it stopped accepting new submissions.

Who was eligible to apply?

Eligibility was broad and included:

  • Public and state-controlled institutions of higher education
  • Private institutions of higher education
  • State governments
  • County governments
  • City or township governments
  • Native American tribal governments (federally recognized)
  • Other Native American tribal organizations
  • Other eligible agencies of the federal government (as described in the opportunity materials)

Why were academic institutions and governments included in eligibility?

Based on the announcement’s framing, the program was structured to allow participation from entities that could credibly plan an integrated safety-and-liability reform model and position it for later real-world demonstration work.

Where can someone find the full official funding notice?

The notice pointed to the NIH-hosted grants page: http://grants.nih.gov/grants/guide/pa-files/PAR-11-023.html

Who was listed as the contact for access and linking issues?

The contact listed for access and linking issues was the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.

Why is NIH mentioned if AHRQ was the sponsoring agency?

The funding notice indicated that administrative posting and access support was handled through NIH’s grants infrastructure, even though AHRQ was the sponsoring agency.

Browse more opportunities from the same agency: Agency for Health Care Research and Quality

Browse more opportunities from the same category: Health

Next opportunity: Development of Management Plan Crossroads of the American Revolution National Heritage Area

Previous opportunity: Media Program

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 11 023

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 11 023) also looked into and applied for these:

Funding Opportunity
Addressing TB Control And Lung Health Activities Through The Vietnam National Lung Hospital/National TB Program (NLH/NTP) Apply for RFA PS 11 004

Funding Number: RFA PS 11 004
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $200,000
Advances in Patient Safety through Simulation Research (R18) Apply for PAR 11 024

Funding Number: PAR 11 024
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Patient Safety and Medical Liability Reform Demonstration Projects (R18) Apply for PAR 11 025

Funding Number: PAR 11 025
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Core Violence and Injury Prevention Program (Core VIPP) Apply for CDC RFA CE11 1101

Funding Number: CDC RFA CE11 1101
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $250,000
Orphans and Vulnerable Children OVC Gender Project in Botswana Apply for 674 11 0002

Funding Number: 674 11 0002
Agency: South Africa USAID Pretoria
Category: Health
Funding Amount: $16,800,000
The Market for Long Term Care Insurance (R01) Apply for RFA RM 11 002

Funding Number: RFA RM 11 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Integrating Comparative Effectiveness Research Findings into Care Delivery through Economic Incentives (R21) Apply for RFA RM 11 001

Funding Number: RFA RM 11 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
National Dental Practice Based Research Network Limited Competition (U19) Apply for RFA DE 12 002

Funding Number: RFA DE 12 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Minority HIV/AIDS Research Initiative (MARI) to Build Capacity in Black and Hispanic Communities and Among Black and Hispanic Researchers to Conduct HIV/AIDS Epidemiologic and Prevention Research Apply for RFA PS 11 003

Funding Number: RFA PS 11 003
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $200,000
Translational Research Centers in Thrombotic and Hemostatic Disorders (TRC THD) (U54) Apply for RFA HL 12 008

Funding Number: RFA HL 12 008
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCR Behavioral or Social Intervention Planning and Pilot Data Grant (R34) Apply for RFA DE 12 001

Funding Number: RFA DE 12 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Translational Tools for Clinical Studies of Mind/Body and Manual Therapy CAM Interventions (R01) Apply for RFA AT 11 003

Funding Number: RFA AT 11 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Functional Genetics, Epigenetics, and Non coding RNAs in Drug Addiction (R01) Apply for PA 11 033

Funding Number: PA 11 033
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Institutional Collaboration Between The Institute Pasteur Of Madagascar And The Centers For Disease Control And Prevention On Malaria And Vector Borne Diseases (U01) Apply for RFA GH 11 003

Funding Number: RFA GH 11 003
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $600,000
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01) Apply for RFA AA 11 006

Funding Number: RFA AA 11 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Integrated Health Social Marketing Program for Mozambique Apply for 656 11 001

Funding Number: 656 11 001
Agency: Mozambique USAID Maputo
Category: Health
Funding Amount: $20,557,019
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Resource and Support Cores (U24) Apply for RFA AA 11 007

Funding Number: RFA AA 11 007
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Social Science Research in Population and Reproductive Health Apply for APS OAA 10 000002

Funding Number: APS OAA 10 000002
Agency: Agency for International Development
Category: Health
Funding Amount: $5,000,000
Sustainable Leadership, Managment and Governance RFA Apply for SOL OAA 11 000009

Funding Number: SOL OAA 11 000009
Agency: Agency for International Development
Category: Health
Funding Amount: $200,000,000
Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) Study to Explore Early Development (SEED) II (U01) Apply for RFA DD 11 002

Funding Number: RFA DD 11 002
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $900,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 11 023", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.